CS logo
small CS logo
Southern District Health Board

Dunedin, New Zealand

About Southern District Health Board


The Southern District Health Board is a district health board with the focus on providing healthcare to an area covering the southern half of the South Island of New Zealand.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Southern District Health Board


During the past decade, Southern District Health Board conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Southern District Health Board" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Southern District Health Board


According to Clinical.Site data, the most researched conditions in "Southern District Health Board" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Heart Failure" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Southern District Health Board" in a lesser frequency.

Clinical Trials Intervention Types at Southern District Health Board


Most popular intervention types in "Southern District Health Board" are "Drug" (9 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "CP-690,550" (2 trials), "Filgotinib" (2 trials), "ALV1 System" (1 trials) and "Andecaliximab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Southern District Health Board


The vast majority of trials in "Southern District Health Board" are 10 trials for "All" genders.

Clinical Trials Status at Southern District Health Board


Currently, there are NaN active trials in "Southern District Health Board". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Southern District Health Board, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Southern District Health Board, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".